PUBLISHER: The Business Research Company | PRODUCT CODE: 1939355
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939355
Biopsy devices are utilized to obtain sample cells or tissues from a patient's body for examination to ascertain the presence of a disease. They play a crucial role in diagnosing diseases, particularly cancer, by allowing healthcare professionals to analyze cellular structures and detect abnormal or cancerous cells.
Key product types within biopsy devices include needle-based biopsy instruments, core biopsy devices, aspiration biopsy needles, vacuum-assisted biopsy devices, biopsy forceps, and localization wires. Core biopsy devices utilize a large hollow needle to make a small incision in the skin over the lump. Imaging technologies associated with these devices include MRI-guided biopsy, stereotactic-guided biopsy, ultrasound-guided biopsy, and CT scan. Applications span breast biopsy, gynecological biopsy, prostate biopsy, liver biopsy, lung biopsy, kidney biopsy, gastroenterology biopsy, and others, with usage in diagnostics and imaging centers, hospitals, and similar medical settings.
Tariffs are influencing the biopsy devices market by increasing costs of imported needles, imaging components, guidance systems, precision instruments, and electronic subsystems. Diagnostic centers and hospitals in North America and Europe are most affected due to reliance on imported biopsy technologies, while Asia-Pacific faces increased manufacturing costs for export markets. These tariffs are raising device prices and extending procurement timelines. However, they are also supporting localized production, regional supplier partnerships, and development of cost-effective biopsy solutions.
The biopsy devices market research report is one of a series of new reports from The Business Research Company that provides biopsy devices market statistics, including biopsy devices industry global market size, regional shares, competitors with a biopsy devices market share, detailed biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the biopsy devices industry. This biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The biopsy devices market size has grown strongly in recent years. It will grow from $3.24 billion in 2025 to $3.53 billion in 2026 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to rising cancer screening rates, expansion of diagnostic imaging centers, increased use of biopsy procedures for early diagnosis, availability of advanced imaging modalities, growth in hospital diagnostic capabilities.
The biopsy devices market size is expected to see strong growth in the next few years. It will grow to $4.95 billion in 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing adoption of AI-assisted biopsy guidance, rising demand for outpatient diagnostic procedures, expansion of precision oncology practices, growing focus on early disease detection, increasing investments in advanced biopsy technologies. Major trends in the forecast period include increasing adoption of image-guided biopsy systems, rising use of minimally invasive biopsy techniques, growing demand for precision sampling devices, expansion of automated biopsy guidance technologies, enhanced focus on diagnostic accuracy.
An increasing number of surgeries is anticipated to drive the growth of the biopsy devices market. Surgery is a medical field dedicated to treating injuries, illnesses, and various disorders through manual and instrumental techniques. Biopsy devices are commonly used in surgical procedures to extract small tissue samples or clusters of cells for further laboratory examination. For example, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and medical aesthetic practices, cosmetic procedure volumes have risen by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. Consequently, the increasing number of surgeries is fueling the growth of the biopsy devices market moving forward.
Major companies operating in the biopsy devices market are concentrating on the development of advanced solutions such as fine-needle biopsy precision technology to improve diagnostic accuracy and sample integrity. Fine-needle biopsy precision technology involves the engineering of needles with specialized tip designs and robust materials that enhance tissue acquisition while maintaining cellular structure, enabling dependable pathological evaluation. For example, in October 2025, Olympus, a Japan-based medical technology company, introduced the SecureFlex single-use fine-needle biopsy device, which incorporates nitinol construction and a dual-beveled Raptor Tip. This tip facilitates the retrieval of larger, intact tissue samples by reducing tissue loss and enhancing penetration performance. The device also features a multi-layer sheath that allows stable access to complex anatomical regions, including the pancreatic head and uncinate process, without repeated scope repositioning. SecureFlex enables fine-needle biopsy through EUS-FNB for gastrointestinal lesions and supports the collection of high-quality tissue for accurate diagnosis and treatment planning. Overall, the device improves sample quality, procedural efficiency, and safety in endoscopic biopsy procedures.
In June 2023, Quest Diagnostics, a US-based medical laboratories company, successfully acquired Haystack Oncology for an undisclosed amount. This strategic move aims to integrate Haystack Oncology's highly sensitive minimal-residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). Quest Diagnostics plans to leverage this technology in the development of innovative blood-based clinical laboratory services for solid tumor cancers, with availability expected to commence in 2024.
Major companies operating in the biopsy devices market are Becton Dickinson and Company, Hologic Inc, Boston Scientific Corporation, Cook Medical LLC, Argon Medical Devices Inc, Olympus Corporation, Medtronic plc, Stryker Corporation, B Braun Melsungen AG, INRAD Inc, TSK Laboratory, Mauna Kea Technologies, Veran Medical Technologies, Merit Medical Systems Inc, ConMed Corporation, DTR Medical, Gallini Srl, TransMed7 LLC, MDL Srl, Biopsybell Srl
North America was the largest region in the biopsy devices market in 2025. Asia-Pacific was the second largest region in the global biopsy devices market report share. The regions covered in the biopsy devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The biopsy devices market consists of sales of core biopsy guns, core biopsy needles, aspiration biopsy needles, vacuum-assisted biopsy systems, vacuum-assisted biopsy needles, localization wires, procedure trays, and other biopsy devices that are used to diagnose various diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Biopsy Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biopsy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.